Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronika Bahlinger

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Scientific Reports|September 18, 2023
Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial)Johannes Breyer, Markus Eckstein, Danijel Sikic, et al.
The Journal of Pathology. Clinical Research|March 20, 2024
A deep-learning workflow to predict upper tract urothelial carcinoma protein-based subtypes from H&E slides supporting the prioritization of patients for molecular testingMiriam Angeloni, Thomas van Doeveren, Sebastian Lindner, et al.
European Urology|November 13, 2022
Spatial Immunephenotypes of Distant Metastases but not Matched Primary Urothelial Carcinomas Predict Response to Immune Checkpoint InhibitionFranziska Erlmeier, Niklas Klümper, Laura Landgraf, et al.
Pharmacological Research|December 5, 2025
Drug targeting of the monocarboxylate transporter MCT4 is a novel treatment strategy for metastatic ccRCCLena-Sophie Menig-Benzig, Viktoria Stühler, Pascale Mazzola, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Scientific Reports|September 18, 2023
Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial)Johannes Breyer, Markus Eckstein, Danijel Sikic, et al.
The Journal of Pathology. Clinical Research|March 20, 2024
A deep-learning workflow to predict upper tract urothelial carcinoma protein-based subtypes from H&E slides supporting the prioritization of patients for molecular testingMiriam Angeloni, Thomas van Doeveren, Sebastian Lindner, et al.
European Urology|November 13, 2022
Spatial Immunephenotypes of Distant Metastases but not Matched Primary Urothelial Carcinomas Predict Response to Immune Checkpoint InhibitionFranziska Erlmeier, Niklas Klümper, Laura Landgraf, et al.
Pharmacological Research|December 5, 2025
Drug targeting of the monocarboxylate transporter MCT4 is a novel treatment strategy for metastatic ccRCCLena-Sophie Menig-Benzig, Viktoria Stühler, Pascale Mazzola, et al.
Pageof 3